cannabis indica

Sistema Endócrino

termo de indexação original: Endocrine System

O acervo do Cannabis Indica reúne 331 estudos científicos que tocam o Sistema Endócrino, publicados entre 2000 e 2024. Pela leitura automatizada, 246 (74%) foram classificados como favoráveis, 40 (12%) como inconclusivos e 45 (14%) como desfavoráveis — uma leitura de máquina, feita para navegar, não para concluir. O desenho mais frequente é metanálise (122 estudos), seguido de estudo em animais (89). As condições mais estudadas dentro deste sistema são Obesidade, Diabetes e Síndrome Metabólica.

Estudos indexados
331
Período coberto
2000–2024
Favoráveis
246 · 74%
Inconclusivos
40 · 12%
Desfavoráveis
45 · 14%
Termo original
Endocrine System

O acervo em números

Tipo de estudo

Metanálise122
Estudo em Animais89
Ensaio Clínico48
Ensaio Clínico Duplo-Cego37
Estudo Laboratorial27
Metanálise Clínica8

Direção do resultado

Favorável246
Inconclusivo40
Desfavorável45

Por década

2000s47
2010s157
2020s127

331 estudos

Filtrar e buscar no acervo →

Esta página mostra 300 dos 331 estudos indexados sobre o tema, dos mais recentes aos mais antigos. Abra o acervo com este filtro para percorrer todos, ou baixe a lista completa em JSON e CSV.

  1. 2024

    Cold-induced changes in plasma signaling lipids are associated with a healthier cardiometabolic profile independently of brown adipose tissue

  2. 2024

    Dietary linoleic acid lowering alone does not lower arachidonic acid or endocannabinoids among women with overweight and obesity: A randomized, controlled trial

  3. 2024

    Examining the oleoylethanolamide supplement effects on glycemic status, oxidative stress, inflammation, and anti-mullerian hormone in polycystic ovary syndrome

    FavorávelEnsaio Clínico Duplo-CegoSíndrome dos Ovários PolicísticosOleoiletanolamida (OEA)
  4. 2024

    Is marijuana a foe of male sexuality? Data from a large cohort of men with sexual dysfunction

    FavorávelMetanáliseLibidoDisfunção Erétil
  5. 2024

    Nutrient composition of different energy-restricted diets determines plasma endocannabinoid profiles and adipose tissue DAGL-α expression; a 12-week randomized controlled trial in subjects with abdominal obesity

  6. 2024

    Perioperative Cannabis Use in Bariatric Patients: A Review of Outcomes and Proposed Clinical Pathway for Management

    DesfavorávelMetanáliseDorDependência QuímicaEfeitos Adversos da Cannabis+10
  7. 2024

    Seventeen years since rimonabant's downfall: reassessing its suicidality risk profile

  8. 2024

    The circulating and central endocannabinoid system in obesity and weight loss

    InconclusivoMetanáliseObesidadeAnandamida (AEA)Endocanabinoide (não especificado)+1
  9. 2024

    Update on cannabis in human sexuality

    FavorávelMetanáliseInfertilidade MasculinaLibidoDisfunção Erétil+1
  10. 2023

    A Phase I Randomized, Double-blind, Placebo-controlled Study on Efficacy and Safety Profile of a Sublingually Administered Cannabidiol /Delta 9-tetrahydrocannabidiol (10: 1) Regimen in Diabetes Type 2 Patients

    FavorávelEnsaio Clínico Duplo-CegoDiabetesSíndrome Metabólica
  11. 2023

    A Randomized, Controlled Trial of Efficacy and Safety of Cannabidiol in Idiopathic and Diabetic Gastroparesis

  12. 2023

    Almond Consumption for 8 Weeks Altered Host and Microbial Metabolism in Comparison to a Control Snack in Young Adults

  13. 2023

    Cannabinoid Hyperemesis Syndrome in a 23-Year-Old Woman with Uncontrolled Type 1 Diabetes Mellitus

  14. 2023

    Cyclodextrin Conjugated α-Bisabolol Suppresses FAK Phosphorylation and Induces Apoptosis in Pancreatic Cancer

    FavorávelEstudo em AnimaisCâncerCâncer — Pâncreas
  15. 2023

    Effects of CB1R inverse agonist, INV-202, in patients with features of metabolic syndrome. A randomized, placebo-controlled, double-blind phase 1b study

    FavorávelEnsaio Clínico Duplo-CegoObesidadeSíndrome MetabólicaEndocanabinoide (não especificado)
  16. 2023

    The endogenous cannabinoid system modulates male sexual behavior expression

  17. 2023

    Therapeutic effect of cannabidiol on myocardial arachidonic acid content in various lipid fractions in a rat model of obesity

  18. 2022

    (Wh)olistic (E)ndocannabinoidome-Microbiome-Axis Modulation through (N)utrition (WHEN) to Curb Obesity and Related Disorders

  19. 2022

    A Low Dose of Pure Cannabidiol Is Sufficient to Stimulate the Cytotoxic Function of CIK Cells without Exerting the Downstream Mediators in Pancreatic Cancer Cells

    FavorávelEstudo LaboratorialCâncerInflamaçãoCâncer — Pâncreas
  20. 2022

    A randomized controlled trial assessing the safety and efficacy of palmitoylethanolamide for treating diabetic-related peripheral neuropathic pain

    FavorávelEnsaio Clínico Duplo-CegoDorInflamaçãoAnsiedadeAnandamida (AEA)Palmitoiletanolamida (PEA)+6
  21. 2022

    Acute pancreatitis as a rare adverse event among cannabis users: A systematic review

    DesfavorávelMetanáliseDorInflamaçãoEfeitos Adversos da CannabisAnandamida (AEA)+17
  22. 2022

    Analysis of 2-Arachidonoylglycerol Levels in Polycystic Ovary Syndrome in the Context of Hormonal and Metabolic Alterations and Across the Classical Phenotypes

  23. 2022

    Antitumor Effects of Cannabinoids in Human Pancreatic Ductal Adenocarcinoma Cell Line (Capan-2)-Derived Xenograft Mouse Model

    FavorávelEstudo em AnimaisCâncerCâncer — PâncreasTetraidrocanabinol (THC)
  24. 2022

    Cannabidiol Downregulates Myocardial de Novo Ceramide Synthesis Pathway in a Rat Model of High-Fat Diet-Induced Obesity

    FavorávelEstudo em AnimaisDoenças Cardiovasculares (DCV)ObesidadeSíndrome Metabólica
  25. 2022

    Cannabidiol for the Management of Endometriosis and Chronic Pelvic Pain

    InconclusivoMetanáliseDorDor — CrônicaEndometriose
  26. 2022

    Cannabidiol-Treated Ovariectomized Mice Show Improved Glucose, Energy, and Bone Metabolism With a Bloom in Lactobacillus

    FavorávelEstudo em AnimaisInflamaçãoDiabetesSíndrome Metabólica+3
  27. 2022

    Cannabinoid-Related Acute Pancreatitis: An Update from International Literature and Individual Case Safety Reports

    DesfavorávelMetanáliseEfeitos Adversos da CannabisPancreatiteTHC Farmacêutico
  28. 2022

    Cannabis sativa Extract Induces Apoptosis in Human Pancreatic 3D Cancer Models: Importance of Major Antioxidant Molecules Present Therein

  29. 2022

    Cannabis Use for Endometriosis: Clinical and Legal Challenges in Australia and New Zealand

    FavorávelMetanáliseEndometriose
  30. 2022

    Cannabis Use Is Inversely Associated with Metabolic Disorders in Hepatitis C-Infected Patients (ANRS CO22 Hepather Cohort)

  31. 2022

    Circulating endocannabinoid levels in pregnant women with gestational diabetes mellitus: a case-control study

    DesfavorávelMetanáliseDiabetesGestaçãoAnandamida (AEA)2-Araquidonoilglicerol (2-AG)
  32. 2022

    Cloudy with a chance of munchies: Assessing the impact of recreational marijuana legalization on obesity

    FavorávelMetanáliseEfeitos Adversos da CannabisObesidade
  33. 2022

    Curcumin Protects Diabetic Mice against Isoproterenol-Induced Myocardial Infarction by Modulating CB2 Cannabinoid Receptors

    FavorávelEstudo em AnimaisDiabetesCúrcuma
  34. 2022

    Deprogramming metabolism in pancreatic cancer with a bi-functional GPR55 inhibitor and biased β2 adrenergic agonist

  35. 2022

    Differentiating Diabetic Ketoacidosis and Hyperglycemic Ketosis Due to Cannabis Hyperemesis Syndrome in Adults With Type 1 Diabetes

    InconclusivoMetanáliseEfeitos Adversos da CannabisDiabetesSíndrome Metabólica+1
  36. 2022

    Distinct Effects of Cannabidiol on Sphingolipid Metabolism in Subcutaneous and Visceral Adipose Tissues Derived from High-Fat-Diet-Fed Male Wistar Rats

    FavorávelEstudo em AnimaisDiabetesSíndrome Metabólica
  37. 2022

    Effects of hemp seed alone and combined with aerobic exercise on metabolic parameters, oxidative stress, and neurotrophic factors in young sedentary men

    FavorávelEnsaio Clínico Duplo-CegoEstresse OxidativoSíndrome MetabólicaExercício Físico
  38. 2022

    Engaging the Endocannabinoid System in Neuroendocrine Neoplasms (NENs) potentiates treatment outcomes and null drug resistance

    FavorávelEstudo LaboratorialCâncer — Neuroendócrino
  39. 2022

    Exploring the endocannabinoidome in genetically obese (ob/ob) and diabetic (db/db) mice: Links with inflammation and gut microbiota

  40. 2022

    Fetal Exposure to Cannabis and Childhood Metabolic Outcomes: The Healthy Start Study

    DesfavorávelEnsaio ClínicoDiabetesSíndrome MetabólicaGestaçãoCanabigerol (CBG)Canabinol (CBN)+2
  41. 2022

    Frequent Cannabis Use Moderates the Relationship Between Sexual Dysfunction and Depression Among Female German Adults

    DesfavorávelMetanáliseEfeitos Adversos da CannabisDepressãoDependência — Álcool+3
  42. 2022

    Geraniol ameliorates the progression of high fat-diet/streptozotocin-induced type 2 diabetes mellitus in rats via regulation of caspase-3, Bcl-2, and Bax expression

    FavorávelEstudo em AnimaisDiabetes
  43. 2022

    Herbal Cannabis Use Is Not Associated with Changes in Levels of Endocannabinoids and Metabolic Profile Alterations among Older Adults

  44. 2022

    Hypoglycemic, Hypolipidemic, and Anti-Inflammatory Effects of Beta-Pinene in Diabetic Rats

    FavorávelEstudo em AnimaisInflamaçãoDiabetesSíndrome Metabólica
  45. 2022

    Improved glycemic status, insulin resistance and inflammation after receiving oral oleoylethanolamide supplement in people with prediabetes: a randomized controlled trial

    FavorávelEnsaio Clínico Duplo-CegoInflamaçãoDiabetesSíndrome MetabólicaOleoiletanolamida (OEA)
  46. 2022

    Inhalation of low-dose basil (Ocimum basilicum) essential oil improved cardiovascular health and plasma lipid markers in high fat diet-induced obese rats

  47. 2022

    Palmitoylethanolamide dampens neuroinflammation and anxiety-like behavior in obese mice

  48. 2022

    Performance of urinary liver-type fatty acid-binding protein in diabetic nephropathy: A meta-analysis

  49. 2022

    Rice Bran Lipidome Identifies Novel Phospholipids, Glycolipids, and Oxylipins with Roles in Lipid Metabolism of Hypercholesterolemic Children

  50. 2022

    Role of the endocannabinoid system in the pathophysiology of endometriosis and therapeutic implications

  51. 2022

    Serum Metabolomic Analysis of Male Patients with Cannabis or Amphetamine Use Disorder

  52. 2022

    Sex differences in endocannabinoids during 3 years of Mediterranean diet intervention: Association with insulin resistance and weight loss in a population with metabolic syndrome

  53. 2022

    Sex Differences in the Association Between Cannabis Use and Diabetes Mellitus among U.S. Adults: The National Health and Nutritional Examination Survey, 2013-2018

    FavorávelMetanáliseDiabetes
  54. 2022

    Spinal cannabinoid CB1 or CB2 receptors activation attenuates mechanical allodynia in streptozotocin-induced diabetic rats

  55. 2022

    Targeting the Endocannabinoid System: From the Need for New Therapies to the Development of a Promising Strategy. What About Pancreatic Cancer?

  56. 2022

    Targeting the Endocannabinoidome in Pancreatic Cancer

  57. 2022

    The effect of β-caryophyllene on food addiction and its related behaviors: A randomized, double-blind, placebo-controlled trial

    FavorávelEnsaio Clínico Duplo-CegoAnsiedadeDepressãoObesidadeEndocanabinoide (não especificado)+1
  58. 2022

    The Endocannabinoid System and Physical Activity—A Robust Duo in the Novel Therapeutic Approach against Metabolic Disorders

  59. 2022

    The Metabolic Efficacy of a Cannabidiolic Acid (CBDA) Derivative in Treating Diet- and Genetic-Induced Obesity

  60. 2022

    The Microbiome and Gut Endocannabinoid System in the Regulation of Stress Responses and Metabolism

  61. 2022

    Treatment of Ovarian Hyperstimulation Syndrome in a Mouse Model by Cannabidiol, an Angiogenesis Pathway Inhibitor

    FavorávelEstudo em AnimaisDorCâncerInflamação+17
  62. 2022

    Vitamin D mitigates diabetes-associated metabolic and cognitive dysfunction by modulating gut microbiota and colonic cannabinoid receptor 1

    FavorávelEstudo em AnimaisDisfunção CognitivaObesidadeDiabetesMicrobioma+2
  63. 2021

    (+)-trans-Cannabidiol-2-hydroxy pentyl is a dual CB 1 R antagonist/CB 2 R agonist that prevents diabetic nephropathy in mice

    FavorávelEstudo em AnimaisDorDiabetesSíndrome Metabólica+3
  64. 2021

    A cannabinoid type 2 (CB2) receptor agonist augments NOS-dependent responses of cerebral arterioles during type 1 diabetes

    FavorávelEstudo em AnimaisDiabetesCanabinoides Sintéticos JWH-x
  65. 2021

    A New Clinical Utility for Tubular Markers to Identify Kidney Responders to Saxagliptin Treatment in Adults With Diabetic Nephropathy

  66. 2021

    Acute effects of hemp protein consumption on glycemic and satiety control: results of two randomized crossover trials

    FavorávelEnsaio ClínicoObesidadeDiabetesSíndrome Metabólica
  67. 2021

    An Unexpected Case of Cannabis-Induced Pancreatitis

    DesfavorávelMetanálisePancreatite
  68. 2021

    Anti-Inflammatory and Pro-Autophagy Effects of the Cannabinoid Receptor CB2R: Possibility of Modulation in Type 1 Diabetes

  69. 2021

    Antidiabetic Potential of Naturally Occurring Sesquiterpenes: A Review

    FavorávelMetanáliseDiabetes
  70. 2021

    Associations of Serum Fatty Acid Proportions with Obesity, Insulin Resistance, Blood Pressure, and Fatty Liver: The Cardiovascular Risk in Young Finns Study

  71. 2021

    Attenuation of Oxidative Stress and Inflammatory Response by Chronic Cannabidiol Administration Is Associated with Improved n-6/n-3 PUFA Ratio in the White and Red Skeletal Muscle in a Rat Model of High-Fat Diet-Induced Obesity

    FavorávelEstudo em AnimaisInflamaçãoEstresse OxidativoObesidade+2
  72. 2021

    Beneficial Effects of Akkermansia muciniphila Are Not Associated with Major Changes in the Circulating Endocannabinoidome but Linked to Higher Mono-Palmitoyl-Glycerol Levels as New PPARα Agonists

  73. 2021

    Borneol protects against cerulein-induced oxidative stress and inflammation in acute pancreatitis mice model

    FavorávelEstudo em AnimaisInflamaçãoPancreatite
  74. 2021

    Caloric restriction, physical exercise, and CB1 receptor blockade as an efficient combined strategy for bodyweight control and cardiometabolic status improvement in male rats

  75. 2021

    Cannabidiol - A phytocannabinoid that widely affects sphingolipid metabolism under conditions of brain insulin resistance

    FavorávelEstudo em AnimaisDoenças NeurodegenerativasObesidadeDoença de Alzheimer+2
  76. 2021

    Cannabis sativa as a Treatment for Obesity: From Anti-Inflammatory Indirect Support to a Promising Metabolic Re-Establishment Target

    FavorávelMetanáliseInflamaçãoObesidadeTetraidrocanabivarina (THCV)
  77. 2021

    Cannabis Use Is Inversely Associated with Overweight and Obesity in Hepatitis B Virus-Infected Patients (ANRS CO22 Hepather Cohort)

    FavorávelMetanáliseObesidadeHepatite
  78. 2021

    Cannabis-Induced Pancreatitis in a Young Adult Male

    DesfavorávelMetanálisePancreatite
  79. 2021

    Dysregulation of endocannabinoid concentrations in human subcutaneous adipose tissue in obesity and modulation by omega-3 polyunsaturated fatty acids

  80. 2021

    Effect of Dipeptidyl Peptidase-4 (DPP-4) Inhibition on Biomarkers of Kidney Injury and Vascular Calcification in Diabetic Kidney Disease: A Randomized Controlled Trial

  81. 2021

    Effect of β-Caryophyllene on insulin resistance in skeletal muscle of high fat diet and fructose-induced type-2 diabetic rats

    FavorávelEstudo em AnimaisDiabetesSíndrome Metabólica
  82. 2021

    Evaluation of cannabidiol's inhibitory effect on alpha-glucosidase and its stability in simulated gastric and intestinal fluids

    FavorávelEstudo LaboratorialDiabetes
  83. 2021

    Expression of NF-κB, IL-6, and IL-10 genes, body composition, and hepatic fibrosis in obese patients with NAFLD-Combined effects of oleoylethanolamide supplementation and calorie restriction: A triple-blind randomized controlled clinical trial

    FavorávelEnsaio Clínico Duplo-CegoObesidadeInsuficiência HepáticaEsteatose HepáticaOleoiletanolamida (OEA)
  84. 2021

    Juvenile cannabidiol chronic treatments produce robust changes in metabolic markers in adult male Wistar rats

    InconclusivoEstudo em AnimaisDoenças Cardiovasculares (DCV)DiabetesSíndrome Metabólica+1
  85. 2021

    Linking the Endocannabinoidome with Specific Metabolic Parameters in an Overweight and Insulin-Resistant Population: From Multivariate Exploratory Analysis to Univariate Analysis and Construction of Predictive Models

  86. 2021

    Mediterranean diet consumption affects the endocannabinoid system in overweight and obese subjects: possible links with gut microbiome, insulin resistance and inflammation

  87. 2021

    Metabolic Consequences of Gestational Cannabinoid Exposure

  88. 2021

    Novel CBG Derivatives Can Reduce Inflammation, Pain and Obesity

    FavorávelEstudo em AnimaisDorInflamaçãoDor — CrônicaCanabigerol (CBG)+1
  89. 2021

    Persistent Cannabis Abuse and Risk for Hospitalization for Acute Pancreatitis: A Cross-Sectional Study in United States Hospitals

    DesfavorávelMetanálisePancreatite
  90. 2021

    Phycocyanin inhibits pancreatic cancer metastasis via suppressing epithelial-mesenchymal transition and targeting Akt/β-catenin pathway

    FavorávelEstudo em AnimaisCâncerCâncer — MetastáticoCâncer — PâncreasFicocianina
  91. 2021

    The Effects of Intermittent Hypoxic-Hyperoxic Exposures on Lipid Profile and Inflammation in Patients With Metabolic Syndrome

  92. 2021

    The gut microbiome, endocannabinoids and metabolic disorders

  93. 2021

    The impact of cannabis use on male sexual function: A 10-year, single-center experience

    FavorávelMetanáliseLibidoDisfunção Erétil
  94. 2021

    The sexualised use of cannabis among young sexual minority men: "I'm actually enjoying this for the first time"

    FavorávelEnsaio ClínicoLibidoDisfunção Erétil
  95. 2021

    The use of drug based on technologically processed antibodies to endocannabinoid receptor type 1 in the treatment of obesity in adults: results of a multicenter double blind placebo controlled randomized clinical trial

    FavorávelEnsaio Clínico Duplo-CegoObesidadeEndocanabinoide (não especificado)
  96. 2021

    Understanding the possible role of endocannabinoid system in obesity

  97. 2021

    β-caryophyllene ameliorated obesity-associated airway hyperresponsiveness through some non-conventional targets

    FavorávelEstudo em AnimaisObesidade
  98. 2020

    A Secondary Analysis from a Randomized Trial on the Effect of Plasma Tetrahydrocannabinol Levels on Pain Reduction in Painful Diabetic Peripheral Neuropathy

    FavorávelMetanálise ClínicaDorDor — CrônicaDiabetesTetraidrocanabinol (THC)+1
  99. 2020

    A Survey Exploring the Relationship Between Cannabis Use Characteristics and Sexual Function in Men

    FavorávelMetanáliseLibidoDisfunção Erétil
  100. 2020

    Cannabinol in the spotlight: Toxicometabolomic study and behavioral analysis of zebrafish embryos exposed to the unknown cannabinoid

  101. 2020

    Cannabis Extracts Affected Metabolic Syndrome Parameters in Mice Fed High-Fat/Cholesterol Diet

    InconclusivoEstudo em AnimaisSíndrome MetabólicaEsteatose HepáticaDesequilíbrio do Microbioma
  102. 2020

    Cannabis use is associated with a lower risk of diabetes in chronic hepatitis C-infected patients (ANRS CO22 Hepather cohort)

    FavorávelMetanáliseDiabetesFibroseHepatite+1
  103. 2020

    Cannabis Use Is Associated With Increased Risk for Diabetic Ketoacidosis in Adults With Type 1 Diabetes: Findings From the T1D Exchange Clinic Registry

    DesfavorávelMetanáliseDiabetes
  104. 2020

    Chronic Cannabidiol Administration Attenuates Skeletal Muscle De Novo Ceramide Synthesis Pathway and Related Metabolic Effects in a Rat Model of High-Fat Diet-Induced Obesity

    FavorávelEstudo em AnimaisObesidadeDiabetesSíndrome Metabólica
  105. 2020

    CRISPR/Cas9 gene editing demonstrates metabolic importance of GPR55 in the modulation of GIP release and pancreatic beta cell function

    FavorávelEstudo em AnimaisDiabetesCanabinoides Sintéticos AM-xCanabinoides Sintéticos O-x+1
  106. 2020

    Dietary fatty acid intake and gut microbiota determine circulating endocannabinoidome signaling beyond the effect of body fat

  107. 2020

    Dietary Hemp Seeds More Effectively Attenuate Disorders in Genetically Obese Rats than Their Lipid Fraction

    FavorávelEstudo em AnimaisObesidadeSíndrome Metabólica
  108. 2020

    Effects of a high protein/low carbohydrate low-calorie diet versus a standard low-calorie diet on anthropometric parameters and cardiovascular risk factors, role of polymorphism rs3123554 in the cannabinoid receptor gene type 2 (CB2R)

  109. 2020

    Effects of Perioperative Cannabis Use on Bariatric Surgical Outcomes: a Systematic Review

    FavorávelMetanáliseEfeitos Adversos da CannabisObesidade
  110. 2020

    Endocannabinoid system and cardiometabolic risk factors: A comprehensive systematic review insight into the mechanistic effects of omega-3 fatty acids

  111. 2020

    High fat-fed GPR55 null mice display impaired glucose tolerance without concomitant changes in energy balance or insulin sensitivity but are less responsive to the effects of the cannabinoids rimonabant or Δ(9)-tetrahydrocannabivarin on weight gain

  112. 2020

    Illicit Cannabis Usage as a Management Strategy in New Zealand Women with Endometriosis: An Online Survey

    FavorávelMetanáliseEndometriose
  113. 2020

    Impact of a weight loss and fitness intervention on exercise-associated plasma oxylipin patterns in obese, insulin-resistant, sedentary women

  114. 2020

    Obesity Affects the Microbiota-Gut-Brain Axis and the Regulation Thereof by Endocannabinoids and Related Mediators

  115. 2020

    Oleoylethanolamide supplementation in obese patients newly diagnosed with non-alcoholic fatty liver disease: Effects on metabolic parameters, anthropometric indices, and expression of PPAR-α, UCP1, and UCP2 genes

  116. 2020

    Olfactory Exposure to β-Caryophyllene Increases Testosterone Levels in Women's Saliva

    FavorávelMetanáliseLibido
  117. 2020

    Palmitoylethanolamide counteracts hepatic metabolic inflexibility modulating mitochondrial function and efficiency in diet-induced obese mice

  118. 2020

    Phytocannabinoids: Useful Drugs for the Treatment of Obesity? Special Focus on Cannabidiol

    FavorávelMetanáliseObesidadeDiabetesSíndrome Metabólica
  119. 2020

    Plant-derived natural therapeutics targeting cannabinoid receptors in metabolic syndrome and its complications: A review

    FavorávelMetanáliseEstresse OxidativoDiabetesSíndrome Metabólica+2
  120. 2020

    Prefrontal Cortex Neuromodulation Enhances Frontal Asymmetry and Reduces Caloric Intake in Patients with Morbid Obesity

    FavorávelEnsaio Clínico Duplo-CegoObesidadeEndocanabinoide (não especificado)
  121. 2020

    Targeting the Endocannabinoid CB1 Receptor to Treat Body Weight Disorders: A Preclinical and Clinical Review of the Therapeutic Potential of Past and Present CB1 Drugs

    FavorávelMetanáliseObesidade
  122. 2020

    The effect of α-terpineol enantiomers on biomarkers of rats fed a high-fat diet

    FavorávelEstudo em AnimaisInflamaçãoEstresse OxidativoObesidade+2
  123. 2020

    The effects of recreational cannabis use on glycemic outcomes and self-management behaviours in people with type 1 and type 2 diabetes: a rapid review

    DesfavorávelMetanáliseDiabetesSíndrome Metabólica
  124. 2020

    Therapeutic Potential of β-Caryophyllene: A Dietary Cannabinoid in Diabetes and Associated Complications

    FavorávelMetanáliseDiabetes
  125. 2020

    Whey protein supplementation reducing fasting levels of anandamide and 2-AG without weight loss in pre-menopausal women with obesity on a weight-loss diet

  126. 2020

    β-caryophyllene improves sexual performance via modulation of crucial enzymes relevant to erectile dysfunction in rats

    InconclusivoEstudo em AnimaisLibidoDisfunção Erétil
  127. 2020

    Δ9-Tetrahydrocannabivarin (THCV): a commentary on potential therapeutic benefit for the management of obesity and diabetes

  128. 2019

    “HASH”ing out pancreatitis: the new increasingly common culprit

    DesfavorávelMetanálisePancreatite
  129. 2019

    A Rare Case of Cannabis-induced Acute Pancreatitis

    DesfavorávelMetanálisePancreatite
  130. 2019

    Associations Between Cannabis Use and Cardiometabolic Risk Factors: A Longitudinal Study of Men

    FavorávelMetanáliseDoenças Cardiovasculares (DCV)Síndrome Metabólica
  131. 2019

    Blood-brain barrier disturbances in diabetes-associated dementia: Therapeutic potential for cannabinoids.

    FavorávelMetanáliseDisfunção CognitivaDiabetes
  132. 2019

    Cannabidiol improves metabolic dysfunction in middle-aged diabetic rats submitted to a chronic cerebral hypoperfusion

    FavorávelEstudo em AnimaisDoenças Cardiovasculares (DCV)Diabetes
  133. 2019

    Cannabidiol induces antidepressant and anxiolytic-like effects in experimental type-1 diabetic animals by multiple sites of action

    FavorávelEstudo em AnimaisAnsiedadeDepressãoDiabetes
  134. 2019

    Cannabis: From a Plant That Modulates Feeding Behaviors toward Developing Selective Inhibitors of the Peripheral Endocannabinoid System for the Treatment of Obesity and Metabolic Syndrome

  135. 2019

    Diabetes Canada Position Statement on Recreational Cannabis Use in Adults and Adolescents With Type 1 and Type 2 Diabetes

    InconclusivoMetanáliseDiabetes
  136. 2019

    Effect of acute Δ9-tetrahydrocannabinol administration on subjective and metabolic hormone responses to food stimuli and food intake in healthy humans: a randomized, placebo-controlled study

  137. 2019

    Effects of Cannabidiol on Diabetes Outcomes and Chronic Cerebral Hypoperfusion Comorbidities in Middle-Aged Rats

    FavorávelEstudo em AnimaisDisfunção CognitivaDiabetes
  138. 2019

    Effects of Cannabinoids on Female Sexual Function

    FavorávelMetanáliseLibidoDisfunção Erétil
  139. 2019

    Effects of Cannabis Use in Youth and Young Adults With Type 1 Diabetes: The Highs, the Lows, the Don't Knows

    InconclusivoMetanáliseEfeitos Adversos da CannabisDiabetes
  140. 2019

    Flavonoid Derivative of Cannabis Demonstrates Therapeutic Potential in Preclinical Models of Metastatic Pancreatic Cancer

    FavorávelEstudo em AnimaisCâncerCâncer — MetastáticoCâncer — Pâncreas
  141. 2019

    How Cannabis Alters Sexual Experience: A Survey of Men and Women

    FavorávelMetanáliseLibidoDisfunção Erétil
  142. 2019

    Lifestyle and Metabolic Syndrome: Contribution of the Endocannabinoidome

  143. 2019

    Lifetime marijuana use in relation to insulin resistance in lean, overweight, and obese US adults

    FavorávelMetanáliseObesidadeDiabetesSíndrome Metabólica
  144. 2019

    N-Palmitoylethanolamide-Oxazoline Protects against Middle Cerebral Artery Occlusion Injury in Diabetic Rats by Regulating the SIRT1 Pathway

    FavorávelEstudo em AnimaisInflamaçãoEstresse OxidativoDiabetesPalmitoiletanolamida (PEA)+1
  145. 2019

    Naturally occurring compounds as pancreatic cancer therapeutic

    FavorávelMetanáliseDorCâncerInsônia e Distúrbios do Sono+3
  146. 2019

    Potential Use of Cannabinoids for the Treatment of Pancreatic Cancer

  147. 2019

    Role of Cannabinoid Receptor Type 1 in Insulin Resistance and Its Biological Implications

  148. 2019

    Self-management strategies amongst Australian women with endometriosis: a national online survey

    FavorávelMetanáliseEndometriose
  149. 2019

    Self-Reported Efficacy of Cannabis for Endometriosis Pain

    FavorávelMetanáliseEndometriose
  150. 2019

    Tetrahydrocannabinolic acid A (THCA-A) reduces adiposity and prevents metabolic disease caused by diet-induced obesity

    FavorávelEstudo em AnimaisSíndrome MetabólicaÁcido Tetraidrocanabinólico (THC-a)
  151. 2019

    The effects of delta-9-tetrahydrocannabinol on Krüppel-like factor-4 expression, redox homeostasis, and inflammation in the kidney of diabetic rat

    FavorávelEstudo em AnimaisInflamaçãoDiabetesNefropatia Diabética
  152. 2019

    The Expanded Endocannabinoid System/Endocannabinoidome as a Potential Target for Treating Diabetes Mellitus

    FavorávelMetanáliseDiabetesEndocanabinoide (não especificado)Microbioma
  153. 2019

    The influence of the fatty acid amide hydrolase 385C>A single nucleotide polymorphisms on obesity susceptibility

  154. 2019

    The Relationship between Cannabis and Male Infertility, Sexual Health, and Neoplasm: a Systematic Review

    InconclusivoMetanáliseCâncerCâncer — PróstataInfertilidade Masculina+4
  155. 2019

    The Relationship between Marijuana Use Prior to Sex and Sexual Function in Women

    FavorávelMetanáliseLibidoDisfunção Erétil
  156. 2018

    A Phytol-Enriched Diet Activates PPAR-α in the Liver and Brown Adipose Tissue to Ameliorate Obesity-Induced Metabolic Abnormalities

    FavorávelEstudo em AnimaisObesidadeSíndrome Metabólica
  157. 2018

    A prospective and longitudinal study of plasma phospholipid saturated fatty acid profile in relation to cardiometabolic biomarkers and the risk of gestational diabetes

  158. 2018

    Association of vascular indices with novel circulating biomarkers as prognostic factors for cardiovascular complications in patients with type 2 diabetes mellitus

  159. 2018

    Cannabinoids in health and disease: pharmacological potential in metabolic syndrome and neuroinflammation

    FavorávelMetanáliseSíndrome MetabólicaPerda de Apetite
  160. 2018

    Chronic cannabidiol exposure promotes functional impairment in sexual behavior and fertility of male mice.

    DesfavorávelEstudo em AnimaisLibidoDisfunção Erétil
  161. 2018

    Common polymorphism in the cannabinoid receptor gene type 2 (CB2R) rs3123554 are associated with metabolic changes after two different hypocaloric diets with different dietary fatty profiles

    FavorávelEnsaio ClínicoObesidadeSíndrome Metabólica
  162. 2018

    Effects of a Weight Loss Program on Metabolic Syndrome, Eating Disorders and Psychological Outcomes: Mediation by Endocannabinoids?

  163. 2018

    Effects of cannabis use on body mass, fasting glucose and lipids during the first 12 months of treatment in schizophrenia spectrum disorders

    InconclusivoMetanáliseEsquizofreniaObesidadeSíndrome Metabólica+1
  164. 2018

    Effects of polymorphism rs3123554 in the cannabinoid receptor gene type 2 (CB2R) on metabolic and adiposity parameters after weight loss with two hypocaloric diets

    FavorávelEnsaio Clínico Duplo-CegoDoenças Cardiovasculares (DCV)ObesidadeDiabetesEndocanabinoide (não especificado)+2
  165. 2018

    Endocannabinoids in Body Weight Control

    FavorávelMetanáliseObesidadeAnandamida (AEA)2-Araquidonoilglicerol (2-AG)+7
  166. 2018

    GPR55 signalling promotes proliferation of pancreatic cancer cells and tumour growth in mice, and its inhibition increases effects of gemcitabine.

    FavorávelEstudo em AnimaisCâncerCâncer — Pâncreas
  167. 2018

    Peripheral Endocannabinoids Associated With Energy Expenditure in Native Americans of Southwestern Heritage

  168. 2018

    Phytol Stimulates the Browning of White Adipocytes Through the Activation of AMP-activated Protein Kinase (AMPK) α in Mice Fed High-Fat Diet

    FavorávelEstudo em AnimaisObesidadeSíndrome Metabólica
  169. 2018

    Role of Cannabinoids in Obesity

    FavorávelMetanáliseObesidadeAnandamida (AEA)2-Araquidonoilglicerol (2-AG)+3
  170. 2018

    Role of Endocannabinoids on Sweet Taste Perception, Food Preference, and Obesity-related Disorders

  171. 2018

    Spirulina maxima Extract Reduces Obesity through Suppression of Adipogenesis and Activation of Browning in 3T3-L1 Cells and High-Fat Diet-Induced Obese Mice

    FavorávelEstudo em AnimaisObesidadeDiabetesSíndrome MetabólicaFicocianina
  172. 2018

    The Inhibitory Effects of Cobalt Protoporphyrin IX and Cannabinoid 2 Receptor Agonists in Type 2 Diabetic Mice.

  173. 2018

    Theoretical Explanation for Reduced Body Mass Index and Obesity Rates in Cannabis Users

  174. 2018

    Δ9-Tetrahydrocannabinol Prevents Cardiovascular Dysfunction in STZ-Diabetic Wistar-Kyoto Rats.

  175. 2017

    Ameliorative effect of borneol, a natural bicyclic monoterpene against hyperglycemia, hyperlipidemia and oxidative stress in streptozotocin-induced diabetic Wistar rats

    FavorávelEstudo em AnimaisInflamaçãoDoenças Cardiovasculares (DCV)Diabetes
  176. 2017

    Association Between Marijuana Use and Sexual Frequency in the United States: A Population-Based Study

    FavorávelMetanáliseLibidoDisfunção Erétil
  177. 2017

    Blockade of CB1 cannabinoid receptor alters gut microbiota and attenuates inflammation and diet-induced obesity.

    FavorávelEstudo em AnimaisInflamaçãoObesidadeDiabetesCanabinoides Sintéticos SR-xMicrobioma+2
  178. 2017

    Clinical Profile of Cannabis-Associated Acute Pancreatitis

    DesfavorávelMetanálisePancreatite
  179. 2017

    Dual therapy targeting the endocannabinoid system prevents experimental diabetic nephropathy.

    FavorávelEstudo em AnimaisNefropatia DiabéticaCanabinoides Sintéticos AM-x
  180. 2017

    Effect of Marijuana Use on Thyroid Function and Autoimmunity.

    FavorávelMetanáliseHipertireoidismo e Doença de Graves
  181. 2017

    Endocannabinoid receptor blockade increases vascular endothelial growth factor and inflammatory markers in obese women with polycystic ovary syndrome

    InconclusivoEnsaio ClínicoSíndrome dos Ovários PolicísticosCanabinoides Sintéticos SR-x
  182. 2017

    Endocannabinoid receptor blockade reduces alanine aminotransferase in polycystic ovary syndrome independent of weight loss

  183. 2017

    Endocannabinoid system in sexual motivational processes: Is it a novel therapeutic horizon?

  184. 2017

    Geraniol Alleviates Diabetic Cardiac Complications: Effect on Cardiac Ischemia and Oxidative Stress

    FavorávelEstudo em AnimaisDoenças Cardiovasculares (DCV)Estresse OxidativoDiabetes+1
  185. 2017

    Incretin secretion in humans is under the influence of cannabinoid receptors

    InconclusivoEnsaio Clínico Duplo-CegoObesidadeSíndrome MetabólicaTHC Farmacêutico
  186. 2017

    Individual prolactin reactivity modulates response of nucleus accumbens to erotic stimuli during acute cannabis intoxication: an fMRI pilot study

    FavorávelEnsaio ClínicoLibidoDisfunção Erétil
  187. 2017

    Masturbation to Orgasm Stimulates the Release of the Endocannabinoid 2-Arachidonoylglycerol in Humans.

    FavorávelEnsaio Clínico Duplo-CegoLibidoDisfunção ErétilAnandamida (AEA)2-Araquidonoilglicerol (2-AG)+1
  188. 2017

    Micronized palmitoylethanolamide/trans-polydatin treatment of endometriosis-related pain: a meta-analysis

    FavorávelMetanáliseDorDor — CrônicaEndometriosePalmitoiletanolamida (PEA)
  189. 2017

    Obesity-Related CKD: When Kidneys Get the Munchies

    InconclusivoMetanáliseObesidadeDoença Renal Crônica
  190. 2017

    Peripheral cannabinoid-1 receptor blockade restores hypothalamic leptin signaling

    FavorávelEstudo em AnimaisObesidadeCanabinoide Sintético (não especificado)
  191. 2017

    Restored Plasma Anandamide and Endometrial Expression of Fatty Acid Amide Hydrolase in Women With Polycystic Ovary Syndrome by the Combination Use of Diane-35 and Metformin

  192. 2017

    Severity and outcomes of acute alcoholic pancreatitis in cannabis users.

    FavorávelMetanálisePancreatite
  193. 2017

    The Anticancer Effects of Novel α-Bisabolol Derivatives Against Pancreatic Cancer

    FavorávelEstudo LaboratorialCâncerCâncer — Pâncreas
  194. 2017

    The Clinical Significance of Endocannabinoids in Endometriosis Pain Management

    FavorávelMetanáliseEndometrioseAnandamida (AEA)Tetraidrocanabinol (THC)+6
  195. 2017

    The Effect of Cannabis Consumption on the Development and Severity of Acute Pancreatitis

    InconclusivoMetanálisePancreatite
  196. 2016

    A cross-sectional analysis of the association between marijuana and cigarette smoking with metabolic syndrome among adults in the United States

  197. 2016

    Cannabidiol promotes browning in 3T3-L1 adipocytes

    FavorávelEstudo LaboratorialObesidadeSíndrome Metabólica
  198. 2016

    Decreased Expression of Fatty Acid Amide Hydrolase in Women With Polycystic Ovary Syndrome

  199. 2016

    Effects of Tangshen Formula on urinary and plasma liver-type fatty acid binding protein levels in patients with type 2 diabetic kidney disease: post-hoc findings from a multi-center, randomized, double-blind, placebo-controlled trial investigating the efficacy and safety of Tangshen Formula in patients with type 2 diabetic kidney disease

  200. 2016

    Efficacy and Safety of Cannabidiol and Tetrahydrocannabivarin on Glycemic and Lipid Parameters in Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Pilot Study.

    FavorávelEnsaio Clínico Duplo-CegoDiabetesEsteatose HepáticaTetraidrocanabivarina (THCV)
  201. 2016

    Endocannabinoid receptor blockade increases hepatocyte growth factor and reduces insulin levels in obese women with polycystic ovary syndrome

  202. 2016

    Experimental cannabidiol treatment reduces early pancreatic inflammation in type 1 diabetes.

    FavorávelEstudo em AnimaisDiabetes
  203. 2016

    Fetal Syndrome of Endocannabinoid Deficiency (FSECD) In Maternal Obesity

    InconclusivoMetanáliseObesidadeGestação
  204. 2016

    Geraniol Improves the Impaired Vascular Reactivity in Diabetes and Metabolic Syndrome Through Calcium Channel Blocking Effect

    FavorávelEstudo em AnimaisDiabetesSíndrome Metabólica
  205. 2016

    Got Munchies? Estimating the Relationship between Marijuana Use and Body Mass Index.

    FavorávelMetanáliseObesidadeDiabetesSíndrome Metabólica+1
  206. 2016

    Impact of teneligliptin on oxidative stress and endothelial function in type 2 diabetes patients with chronic kidney disease: a case-control study

  207. 2016

    Lysophosphatidylinositol Signalling and Metabolic Diseases

  208. 2016

    Marijuana Use and Type 2 Diabetes Mellitus: a Review.

    FavorávelMetanáliseDiabetes
  209. 2016

    Maximizing retention in long-term clinical trials of a weight loss agent: use of a dietitian support team

    FavorávelEnsaio ClínicoObesidadeEndocanabinoide (não especificado)Dieta
  210. 2016

    Metabolic syndrome in people with a psychotic illness: is cannabis protective?

    FavorávelMetanáliseSíndrome Metabólica
  211. 2016

    Phycocyanin Inhibits Tumorigenic Potential of Pancreatic Cancer Cells: Role of Apoptosis and Autophagy

    FavorávelEstudo em AnimaisCâncerCâncer — PâncreasFicocianina
  212. 2016

    The novel cannabinoid antagonist SM-11 reduces hedonic aspect of food intake through a dopamine-dependent mechanism

  213. 2016

    α-Bisabolol Inhibits Invasiveness and Motility in Pancreatic Cancer Through KISS1R Activation

    FavorávelEstudo LaboratorialCâncerCâncer — Pâncreas
  214. 2015

    A 4-week pilot study with the cannabinoid receptor agonist dronabinol and its effect on metabolic parameters in a randomized trial

    FavorávelEnsaio Clínico Duplo-CegoDorDoenças Cardiovasculares (DCV)Dor — AgudaTHC Farmacêutico+4
  215. 2015

    Cannabis Smoking and Diabetes Mellitus: Results from Meta-Analysis with Eight Independent Replication Sample.

    FavorávelMetanáliseDiabetes
  216. 2015

    Cannabis Use and Reduced Risk of Insulin Resistance in HIV-HCV Infected Patients: A Longitudinal Analysis (ANRS CO13 HEPAVIH)

    FavorávelMetanáliseDiabetesSíndrome MetabólicaHIV/AIDS+1
  217. 2015

    Cannabis use in relation to obesity and insulin resistance in the Inuit population.

    FavorávelMetanáliseObesidadeDiabetesSíndrome Metabólica
  218. 2015

    Endocannabinoid system activation may be associated with insulin resistance in women with polycystic ovary syndrome

  219. 2015

    Palmitoylethanolamide treatment reduces retinal inflammation in streptozotocin-induced diabetic rats

    FavorávelEstudo em AnimaisDorInflamaçãoDiabetesPalmitoiletanolamida (PEA)+2
  220. 2015

    Prevention of Diet-Induced Obesity Effects on Body Weight and Gut Microbiota in Mice Treated Chronically with Δ9-Tetrahydrocannabinol.

    FavorávelEstudo em AnimaisObesidadeDesequilíbrio do Microbioma
  221. 2015

    Reduction of serum FABP4 level by sitagliptin, a DPP-4 inhibitor, in patients with type 2 diabetes mellitus

  222. 2015

    Selected CNR1 polymorphisms and hyperandrogenemia as well as fat mass and fat distribution in women with polycystic ovary syndrome

    FavorávelEstudo LaboratorialSíndrome dos Ovários Policísticos
  223. 2015

    Single dose delta-9-tetrahydrocannabinol in chronic pancreatitis patients: analgesic efficacy, pharmacokinetics and tolerability

  224. 2014

    A role for trans-caryophyllene in the moderation of insulin secretion.

    FavorávelEstudo LaboratorialDiabetes
  225. 2014

    Cannabinoid receptor 1 gene polymorphisms and nonalcoholic Fatty liver disease in women with polycystic ovary syndrome and in healthy controls

    InconclusivoMetanáliseEsteatose HepáticaSíndrome dos Ovários Policísticos
  226. 2014

    Curcuminoids Target Decreasing Serum Adipocyte-fatty Acid Binding Protein Levels in Their Glucose-lowering Effect in Patients with Type 2 Diabetes

    FavorávelEnsaio ClínicoInflamaçãoEstresse OxidativoObesidadeCúrcuma+2
  227. 2014

    Dairy fat intake is associated with glucose tolerance, hepatic and systemic insulin sensitivity, and liver fat but not β-cell function in humans

  228. 2014

    Differences in the prospective association between individual plasma phospholipid saturated fatty acids and incident type 2 diabetes: the EPIC-InterAct case-cohort study

    FavorávelMetanáliseDiabetesSíndrome MetabólicaÁcido Pentadecanoico (C15:0)
  229. 2014

    Emerging Issues for our Nation's Health: The Intersection of Marijuana Use and Cardiometabolic Disease Risk

    InconclusivoMetanáliseSíndrome Metabólica
  230. 2014

    Influence of dietary fat intake on the endocannabinoid system in lean and obese subjects

  231. 2014

    Moderate-vigorous physical activity across body mass index in females: moderating effect of endocannabinoids and temperament

  232. 2014

    Potential first trimester metabolomic biomarkers of abnormal birth weight in healthy pregnancies

  233. 2014

    Protective effects of geraniol (a monoterpene) in a diabetic neuropathy rat model: attenuation of behavioral impairments and biochemical perturbations

    FavorávelEstudo em AnimaisInflamaçãoEstresse OxidativoDoenças Neurodegenerativas+3
  234. 2014

    Repositioning therapy for thyroid cancer: new insights on established medications

    FavorávelMetanáliseCâncerCâncer — Tireoide
  235. 2014

    Serum pentadecanoic acid (15:0), a short-term marker of dairy food intake, is inversely associated with incident type 2 diabetes and its underlying disorders

  236. 2014

    The endocannabinoid system and appetite: relevance for food reward

  237. 2014

    The influence of endocannabinoid receptor 1 gene variations on anthropometric and metabolic parameters of women with polycystic ovary syndrome

    InconclusivoMetanáliseSíndrome dos Ovários Policísticos
  238. 2013

    Antioxidative properties and inhibition of key enzymes relevant to type-2 diabetes and hypertension by essential oils from black pepper

    FavorávelEstudo LaboratorialDoenças Cardiovasculares (DCV)DiabetesHipertensão Arterial
  239. 2013

    Cannabis-induced acute pancreatitis

    DesfavorávelMetanálisePancreatite
  240. 2013

    Cannabis: a rare cause of acute pancreatitis

    DesfavorávelMetanálisePancreatite
  241. 2013

    CB1 Cannabinoid Receptors Couple to Focal Adhesion Kinase to Control Insulin Release.

    FavorávelEstudo em AnimaisDiabetesAnandamida (AEA)Endocanabinoide (não especificado)+7
  242. 2013

    Chronic treatment with krill powder reduces plasma triglyceride and anandamide levels in mildly obese men

    FavorávelEnsaio ClínicoObesidadeÔmega-3
  243. 2013

    Comparative proteomic and phosphoproteomic profiling of pancreatic adenocarcinoma cells treated with CB1 or CB2 agonists

    FavorávelEstudo LaboratorialCâncerCâncer — PâncreasCanabinoide Sintético (não especificado)
  244. 2013

    Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity

  245. 2013

    Fat to treat fat: Emerging relationship between dietary PUFA, endocannabinoids, and obesity

    FavorávelMetanáliseObesidadeSíndrome MetabólicaDieta
  246. 2013

    Metabolic effects of chronic cannabis smoking

    DesfavorávelEnsaio ClínicoEfeitos Adversos da CannabisDoenças Cardiovasculares (DCV)Diabetes+3
  247. 2013

    Preventive and ameliorating effects of citrus D-limonene on dyslipidemia and hyperglycemia in mice with high-fat diet-induced obesity

    FavorávelEstudo em AnimaisObesidadeDiabetesSíndrome Metabólica
  248. 2013

    The cannabinoid Δ9-tetrahydrocannabivarin (THCV) ameliorates insulin sensitivity in two mouse models of obesity.

  249. 2013

    The impact of marijuana use on glucose, insulin, and insulin resistance among US adults.

    FavorávelMetanáliseObesidadeDiabetesSíndrome Metabólica
  250. 2012

    A systematic review and mixed treatment comparison of pharmacological interventions for the treatment of obesity

    DesfavorávelMetanálise ClínicaObesidadeCanabinoides Sintéticos SR-x
  251. 2012

    Additive renoprotective effects of aliskiren on angiotensin receptor blocker and calcium channel blocker treatments for type 2 diabetic patients with albuminuria

  252. 2012

    Cannabinoid Receptor 1 Blockade Ameliorates Albuminuria in Experimental Diabetic Nephropathy.

    FavorávelEstudo em AnimaisNefropatia DiabéticaCanabinoides Sintéticos AM-x
  253. 2012

    CB(1) blockade-induced weight loss over 48 weeks decreases liver fat in proportion to weight loss in humans

  254. 2012

    Crosstalk between the gut microbiota and the endocannabinoid system: impact on the gut barrier function and the adipose tissue

  255. 2012

    Decreased prevalence of diabetes in marijuana users: cross-sectional data from the National Health and Nutrition Examination Survey (NHANES) III.

    FavorávelMetanáliseDiabetes
  256. 2012

    Efficacy of rimonabant in obese patients with binge eating disorder

  257. 2012

    Fatty acid flux and oxidation are increased by rimonabant in obese women

  258. 2012

    Long-term fenofibrate therapy increases fibroblast growth factor 21 and retinol-binding protein 4 in subjects with type 2 diabetes

  259. 2012

    Progesterone-dependent Regulation of Endometrial Cannabinoid Receptor Type 1 (CB1-R) Expression is Disrupted in Women with Endometriosis and in Isolated Stromal Cells Exposed to TCDD (2,3,7,8-tetrachlorodibenzo-p-dioxin)

    InconclusivoEstudo LaboratorialEndometriose
  260. 2012

    Protective effects of alpha-pinene in mice with cerulein-induced acute pancreatitis

    FavorávelEstudo em AnimaisPancreatite
  261. 2012

    Rimonabant improves obesity but not the overall cardiovascular risk and quality of life; results from CARDIO-REDUSE (CArdiometabolic Risk reDuctIOn by Rimonabant: the Effectiveness in Daily practice and its USE)

  262. 2012

    The l-α-Lysophosphatidylinositol/GPR55 System and Its Potential Role in Human Obesity

  263. 2012

    The role of the endocannabinoid system in skeletal muscle and metabolic adaptations to exercise: potential implications for the treatment of obesity

  264. 2011

    Adipose tissue endocannabinoid system gene expression: depot differences and effects of diet and exercise

  265. 2011

    An overview of the metabolic effects of rimonabant in randomized controlled trials: potential for other cannabinoid 1 receptor blockers in obesity

    InconclusivoMetanálise ClínicaObesidadeCanabinoide Sintético (não especificado)
  266. 2011

    Antitumor effects of α-bisabolol against pancreatic cancer

    FavorávelEstudo em AnimaisCâncerCâncer — Pâncreas
  267. 2011

    Cannabinoids and Endocannabinoids in Metabolic Disorders with Focus on Diabetes

  268. 2011

    Effects of lipid-lowering therapy with rosuvastatin on kidney function and oxidative stress in patients with diabetic nephropathy

  269. 2011

    Effects of the cannabinoid-1 receptor antagonist rimonabant on psychiatric symptoms in overweight people with schizophrenia: a randomized, double-blind, pilot study

    DesfavorávelEnsaio Clínico Duplo-CegoEsquizofreniaObesidadeTHC Farmacêutico
  270. 2011

    Obesity and cannabis use: results from 2 representative national surveys.

    FavorávelMetanáliseObesidade
  271. 2011

    Serum A-FABP is increased and closely associated with elevated NT-proBNP levels in type 2 diabetic patients treated with rosiglitazone

  272. 2011

    The fatty acid amide hydrolase (FAAH) gene variant rs324420 AA/AC is not associated with weight loss in a 1-year lifestyle intervention for obese children and adolescents

    InconclusivoEnsaio ClínicoObesidadeHidrolase de Amidas de Ácidos Graxos (FAAH)
  273. 2010

    A clinical trial assessing the safety and efficacy of taranabant, a CB1R inverse agonist, in obese and overweight patients: a high-dose study

    DesfavorávelEnsaio Clínico Duplo-CegoObesidadeCanabinoide Sintético (não especificado)
  274. 2010

    A clinical trial assessing the safety and efficacy of the CB1R inverse agonist taranabant in obese and overweight patients: low-dose study

    InconclusivoEnsaio Clínico Duplo-CegoObesidade
  275. 2010

    A metabolically stable analogue of anandamide, Met-F-AEA, inhibits human thyroid carcinoma cell lines by activation of apoptosis.

  276. 2010

    A one-year study to assess the safety and efficacy of the CB1R inverse agonist taranabant in overweight and obese patients with type 2 diabetes

    DesfavorávelEnsaio Clínico Duplo-CegoObesidadeDiabetes
  277. 2010

    A randomized trial of lifestyle modification and taranabant for maintaining weight loss achieved with a low-calorie diet

    InconclusivoEnsaio Clínico Duplo-CegoObesidade
  278. 2010

    Antiproliferative Effects of Cannabinoid Agonists on Deep Infiltrating Endometriosis.

    FavorávelEstudo em AnimaisEndometrioseCanabinoides Sintéticos WIN-x
  279. 2010

    Cannabidiol attenuates cardiac dysfunction, oxidative stress, fibrosis, inflammatory and cell death signaling pathways in diabetic cardiomyopathy.

    FavorávelEstudo em AnimaisInflamaçãoDoenças Cardiovasculares (DCV)Estresse Oxidativo+1
  280. 2010

    Effect of palmitoylethanolamide-polydatin combination on chronic pelvic pain associated with endometriosis: preliminary observations

  281. 2010

    Endocannabinoid involvement in endometriosis.

  282. 2010

    Polymorphisms in the endocannabinoid receptor 1 in relation to fat mass distribution

    DesfavorávelEnsaio ClínicoObesidadeDiabetes
  283. 2010

    Psychiatric adverse effects of rimonobant in adults with Prader Willi syndrome

    DesfavorávelEnsaio Clínico Duplo-CegoObesidadeCanabinoide Sintético (não especificado)
  284. 2010

    The endocannabinoid system links gut microbiota to adipogenesis

  285. 2009

    Cannabidiol Arrests Onset of Autoimmune Diabetes in NOD Mice.

    FavorávelEstudo em AnimaisDiabetes
  286. 2009

    Cannabinoid CB(1) receptor activation stimulates neurite outgrowth and inhibits capsaicin-induced Ca(2+) influx in an in vitro model of diabetic neuropathy.

  287. 2009

    Drug reimbursement and GPs' prescribing decisions: a randomized case-vignette study about the pharmacotherapy of obesity associated with type 2 diabetes: how GPs react to drug reimbursement

    DesfavorávelEnsaio ClínicoObesidadeDiabetes
  288. 2009

    Effect of rimonabant on glycemic control in insulin-treated type 2 diabetes: the ARPEGGIO trial

    InconclusivoEnsaio Clínico Duplo-CegoDiabetesCanabinoide Sintético (não especificado)
  289. 2009

    Endocannabinoids may mediate the ability of (n-3) fatty acids to reduce ectopic fat and inflammatory mediators in obese Zucker rats

  290. 2008

    A Comparative Study on Cannabidiol-Induced Apoptosis in Murine Thymocytes and EL-4 Thymoma Cells

    FavorávelEstudo LaboratorialCâncerCâncer — Timo
  291. 2008

    A Pilot Study of Perillyl Alcohol in Pancreatic Cancer

    FavorávelEnsaio ClínicoCâncerCâncer — Pâncreas
  292. 2008

    Cannabinoid 2 receptor induction by IL-12 and its potential as a therapeutic target for the treatment of anaplastic thyroid carcinoma.

  293. 2008

    Cannabinoids in pancreatic cancer: Correlation with survival and pain

    FavorávelEstudo LaboratorialCâncerCâncer — PâncreasAnandamida (AEA)2-Araquidonoilglicerol (2-AG)+2
  294. 2008

    Cannabinoids Reduce Markers of Inflammation and Fibrosis in Pancreatic Stellate Cells.

    FavorávelEstudo LaboratorialPancreatiteAnandamida (AEA)2-Araquidonoilglicerol (2-AG)+2
  295. 2008

    Cost-effectiveness of pharmacological anti-obesity treatments: a systematic review

    DesfavorávelMetanálise ClínicaObesidadeCanabinoides Sintéticos SR-x
  296. 2008

    Dual, time-dependent deleterious and protective effect of anandamide on the course of cerulein-induced acute pancreatitis. Role of sensory nerves.

    FavorávelEstudo em AnimaisPancreatiteAnandamida (AEA)
  297. 2008

    Effect of rimonabant on the high-triglyceride/ low-HDL-cholesterol dyslipidemia, intraabdominal adiposity, and liver fat: the ADAGIO-Lipids trial

    FavorávelEnsaio Clínico Duplo-CegoObesidadeCanabinoide Sintético (não especificado)
  298. 2008

    Influence of taranabant, an orally active, highly selective, potent cannabinoid-1 receptor (CB1R) inverse agonist, on ethinyl estradiol and norelgestromin plasma pharmacokinetics

    FavorávelEnsaio Clínico Duplo-CegoObesidadeGestaçãoCanabinoide Sintético (não especificado)
  299. 2008

    Long-term effect of CB1 blockade with rimonabant on cardiometabolic risk factors: two year results from the RIO-Europe Study

    FavorávelEnsaio Clínico Duplo-CegoObesidade
  300. 2008

    Multiple-dose pharmacokinetics, pharmacodynamics, and safety of taranabant, a novel selective cannabinoid-1 receptor inverse agonist, in healthy male volunteers

    DesfavorávelEnsaio ClínicoObesidadeCanabinoide Sintético (não especificado)

Continue por aqui

Perguntas frequentes

Quantos estudos sobre sistema endócrino estão indexados no acervo?
São 331 estudos, publicados entre 2000 e 2024. O acervo inteiro tem 7.640 registros.
Que tipos de estudo predominam?
Metanálise: 122 · Estudo em Animais: 89 · Ensaio Clínico: 48 · Ensaio Clínico Duplo-Cego: 37 · Estudo Laboratorial: 27 · Metanálise Clínica: 8. A classificação segue o desenho declarado na fonte.
O que significa a classificação de resultado?
É uma leitura automatizada da conclusão de cada estudo, em três direções — favorável, inconclusivo e desfavorável. Aqui são 246 favoráveis, 40 inconclusivos e 45 desfavoráveis. Serve para navegar o acervo, não para concluir nada clinicamente: a conclusão válida é a do artigo original.

Como citar esta página

ABNT

CANNABIS INDICA. Sistema Endócrino — estudos científicos sobre cannabis. 2026. Disponível em: https://cannabisindica.com.br/sistema/sistema-endocrino/. Acesso em: 13 set. 2026.

APA

Cannabis Indica. (2026). Sistema Endócrino — estudos científicos sobre cannabis. https://cannabisindica.com.br/sistema/sistema-endocrino/

Esta página é um índice de acesso. Ao usar um estudo como evidência, cite o artigo original — o link de cada registro leva à fonte.